Nuclea joins medical center to identify cancer biomarkers

06/20/2013 | American City Business Journals

Nuclea Biotechnologies and Berkshire Medical Center agreed to work together to identify biomarkers that can guide the treatment of prostate and breast cancer. "I'm thrilled to be working with the Berkshire Medical Center and confident that this research will advance the use of biomarkers and yield more effective cancer treatments," Nuclea President and CEO Patrick Muraca said.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA